Paper33918655
Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma.
Ito S and 2 others. Cancers (Basel), 2021. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma. Papers, record 33918655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33918655
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References110
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25257340 | Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma. | Ann Hematol | 2015 | https://conductscience.org/library/papers/25257340 | PubMed |
| 2 | 22706492 | Extramedullary involvement: an emerging problem in multiple myeloma. | Clin Adv Hematol Oncol | 2012 | https://conductscience.org/library/papers/22706492 | PubMed |
| 3 | 18598946 | Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18598946 | PubMed |
| 4 | 19568410 | CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. | Neoplasia | 2009 | https://conductscience.org/library/papers/19568410 | PubMed |
| 5 | 20800871 | Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance. | Hum Pathol | 2010 | https://conductscience.org/library/papers/20800871 | PubMed |
| 6 | 26655999 | Targeting SDF-1 in multiple myeloma tumor microenvironment. | Cancer Lett | 2016 | https://conductscience.org/library/papers/26655999 | PubMed |
| 7 | 9064327 | A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) | J Exp Med | 1996 | https://conductscience.org/library/papers/9064327 | PubMed |
| 8 | 25083818 | Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells. | Blood Cancer J | 2014 | https://conductscience.org/library/papers/25083818 | PubMed |
| 9 | 11274763 | Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. | Exp Hematol | 2001 | https://conductscience.org/library/papers/11274763 | PubMed |
| 10 | 23354012 | Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1. | Leukemia | 2013 | https://conductscience.org/library/papers/23354012 | PubMed |
| 11 | 21652011 | Notch-ing from T-cell to B-cell lymphoid malignancies. | Cancer Lett | 2011 | https://conductscience.org/library/papers/21652011 | PubMed |
| 12 | 19487820 | Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19487820 | PubMed |
| 13 | 7964956 | Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. | J Clin Oncol | 1994 | https://conductscience.org/library/papers/7964956 | PubMed |
| 14 | 15882617 | Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. | Cell | 2005 | https://conductscience.org/library/papers/15882617 | PubMed |
| 15 | 24703465 | MGr1-Ag/37LRP induces cell adhesion-mediated drug resistance through FAK/PI3K and MAPK pathway in gastric cancer. | Cancer Sci | 2014 | https://conductscience.org/library/papers/24703465 | PubMed |
| 16 | 17975015 | Improved survival in multiple myeloma and the impact of novel therapies. | Blood | 2008 | https://conductscience.org/library/papers/17975015 | PubMed |
| 17 | 17575106 | Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism. | Mol Cancer Ther | 2007 | https://conductscience.org/library/papers/17575106 | PubMed |
| 18 | 21780290 | PET imaging of CXCR4 receptors in cancer by a new optimized ligand. | ChemMedChem | 2011 | https://conductscience.org/library/papers/21780290 | PubMed |
| 19 | 26582643 | BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia. | Leukemia | 2016 | https://conductscience.org/library/papers/26582643 | PubMed |
| 20 | 21900099 | Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21900099 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42151108 | From complexity to clarity: aging bone marrow niche in bone and blood regeneration and malignancy. | Bone Res | 2026 | https://conductscience.org/library/papers/42151108 | PubMed |
| 42015768 | Xiaotan Sanjie recipe suppressed the oncogenic potential of cancer-associated fibroblaststhe stromal-derived factor 1α/C-X-C chemokine receptor type 4 pathway in gastric cancer. | J Tradit Chin Med | 2026 | https://conductscience.org/library/papers/42015768 | PubMed |
| 41760826 | [68Ga]Ga-Pentixafor PET/CT for Durie-Salmon PLUS staging and risk stratification in newly diagnosed multiple myeloma. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/41760826 | PubMed |
| 41703564 | Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway. | J Transl Med | 2026 | https://conductscience.org/library/papers/41703564 | PubMed |
| 41689663 | Translational immunothrombosis in autoimmune Heparin-Induced thrombocytopenia: targeting the FcγRIIa-Syk-BTK and complement pathways. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/41689663 | PubMed |
| 41188965 | Human preclinical multiple myeloma in vitro models for disease modeling and therapy screening. | J Biol Eng | 2025 | https://conductscience.org/library/papers/41188965 | PubMed |
| 41088352 | Turning cold tumors into hot tumors to ignite immunotherapy. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41088352 | PubMed |
| 40427609 | CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment. | Biomolecules | 2025 | https://conductscience.org/library/papers/40427609 | PubMed |
| 39576660 | Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. | Oncotarget | 2024 | https://conductscience.org/library/papers/39576660 | PubMed |
| 39555055 | Unraveling the role of cancer-associated fibroblasts in B cell lymphoma. | Front Immunol | 2024 | https://conductscience.org/library/papers/39555055 | PubMed |
| 39304574 | Chemokine Receptor 4-Targeted PET/CT with [68Ga]pentixather in Newly Diagnosed Multiple Myeloma: a Comparative Study with [68Ga]pentixafor PET/CT. | Mol Imaging Biol | 2024 | https://conductscience.org/library/papers/39304574 | PubMed |
| 39031503 | Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone. | Cancer Med | 2024 | https://conductscience.org/library/papers/39031503 | PubMed |
| 38690165 | A comparative analysis of transcriptomics of newly diagnosed multiple myeloma: exploring drug repurposing. | Front Oncol | 2024 | https://conductscience.org/library/papers/38690165 | PubMed |
| 37276129 | Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing. | Blood Adv | 2023 | https://conductscience.org/library/papers/37276129 | PubMed |
| 36992255 | Structural and Phylogenetic Analysis of CXCR4 Protein Reveals New Insights into Its Role in Emerging and Re-Emerging Diseases in Mammals. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36992255 | PubMed |
| 35966583 | Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis. | Theranostics | 2022 | https://conductscience.org/library/papers/35966583 | PubMed |
| 35847862 | Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease. | Front Oncol | 2022 | https://conductscience.org/library/papers/35847862 | PubMed |
| 34975909 | Diversity of Vascular Niches in Bones and Joints During Homeostasis, Ageing, and Diseases. | Front Immunol | 2021 | https://conductscience.org/library/papers/34975909 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33918655
GET https://conductscience.org/api/papers/v1/33918655/references?page=2